Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

CHARGE: Controlling Hunger and ReGulating Eating (CHARGE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03678766
Recruitment Status : Recruiting
First Posted : September 20, 2018
Last Update Posted : April 16, 2019
Sponsor:
Collaborators:
San Diego Veterans Healthcare System
United States Department of Defense
Information provided by (Responsible Party):
Kerri Boutelle, University of California, San Diego

Brief Summary:
The objectives of this proposed study are: 1) to evaluate feasibility and acceptability of a novel intervention, Regulation of Cues (ROC), and Cognitive Behavior Therapy (CBT), and 2) to evaluate the efficacy of both treatments on reduction of binge eating and weight loss among 120 Veterans with subclinical or clinical Binge Eating Disorder (BED) with comorbid overweight/obesity (OW/OB).

Condition or disease Intervention/treatment Phase
Binge-Eating Disorder Overweight Obesity Behavioral: Regulation of Cues (ROC) Behavioral: Cognitive Behavior Therapy (CBT) Not Applicable

Detailed Description:
The investigators have developed a new model for the treatment of obesity, called Regulation of Cues (ROC), which is based on Schachter's Externality Theory. This study will compare ROC with Cognitive Behavior Therapy for individuals with Binge Eating Disorder. The investigators will recruit and randomize 120 male and female Veterans with BED and subclinical BED with comorbid overweight/obesity, provide 5 months of treatment and follow participants for 6-months post-treatment. Participants will complete assessments at baseline, mid-treatment (week 9), post-treatment (week 20), and 6-month follow-up (week 44). This study will be the first to contribute to a body of literature developing treatments for BED and overweight/obesity in the Veterans Affairs (VA) and/or military health care systems.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 120 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Targeting Food Cue Reactivity and Satiety Sensitivity to Decrease Binge Eating and Weight
Actual Study Start Date : September 30, 2018
Estimated Primary Completion Date : September 22, 2022
Estimated Study Completion Date : September 22, 2022

Arm Intervention/treatment
Experimental: Regulation of Cues (ROC)
The ROC program provides psychoeducation, coping skills, self-monitoring and experimental learning.
Behavioral: Regulation of Cues (ROC)
Participants are provided information about basic learning theory and how physiological responses to food cues develop and can be managed. Lack of sensitivity to appetite and satiety cues and increased sensitivity to food cues will be discussed. Coping skills are presented to assist in mastery and toleration of food cue sensitivity. Participants will complete experiential learning exercises with food, and taught to monitor their hunger, satiety, and cravings. The physical activity program will focus on increasing both lifestyle activity and structured exercise programs.
Other Name: ROC

Experimental: Cognitive Behavior Therapy (CBT)
CBT provides coping skills, self-monitoring, and goal setting.
Behavioral: Cognitive Behavior Therapy (CBT)
Participants are taught to identify problems in eating, thinking, and mood patterns that served to trigger binge episodes through self-monitoring and to gradually develop alternative patterns aimed at facilitating healthy, binge-free eating patterns. Participants are taught to eat a healthy variety of foods and reducing the avoidance of "forbidden" foods that are typically consumed during a binge.
Other Name: CBT




Primary Outcome Measures :
  1. Attendance [ Time Frame: Post-Treatment (5 months following baseline) ]
    The number of treatment visits attended

  2. Acceptability [ Time Frame: Post-Treatment (5 months following baseline) ]
    Average likert ratings to questions, such as "How much did you enjoy the treatment?" and "How helpful did you find the treatment?"

  3. Binge Eating as measured by the Eating Disorder Examination (EDE) [ Time Frame: Changes from baseline at an average of 9 weeks, 20 weeks, and 44 weeks ]
    Diagnosis of Binge Eating Disorder (BED) and subclinical BED, number of OBEs (large amount of food and loss of control), objective overeating episodes (large amount of food without loss of control), and SBEs (lack of large amount of food with loss of control) determined by responses to the EDE.

  4. Binge Eating as measured by the Binge Eating Scale (BES) [ Time Frame: Changes from baseline at an average of 9 weeks, 20 weeks, and 44 weeks ]
    Dimensional score of binge eating consisting of items to describe binge eating behaviors and feelings and cognitions associated with binge eating.

  5. Binge Eating as measured by the Eating Disorder Examination-Questionnaire (EDE-Q) [ Time Frame: Changes from baseline at an average of 9 weeks, 20 weeks, and 44 weeks ]
    Three question items from the questionnaire to calculate the number of binge eating episodes and number of days participants experienced a binge eating episode.

  6. Body Mass Index (BMI) as measured by weight and height [ Time Frame: Changes from baseline at an average of 9 weeks, 20 weeks, and 44 weeks ]
  7. Energy intake [ Time Frame: Changes from baseline at an average of 20 weeks and 44 weeks ]
    Calorie intake estimated by 24-hour dietary recalls on 3 non-consecutive days


Secondary Outcome Measures :
  1. Satiety Responsiveness [ Time Frame: Changes from baseline at an average of 9 weeks, 20 weeks, and 44 weeks ]
    Self-reported satiety responsiveness measured by the Adult Eating Behavior Questionnaire (AEBQ)

  2. Food Responsiveness [ Time Frame: Changes from baseline at an average of 9 weeks, 20 weeks, and 44 weeks ]
    Self-reported food responsiveness measured by the Adult Eating Behavior Questionnaire (AEBQ)

  3. Reward-Based Eating [ Time Frame: Changes from baseline at an average of 9 weeks, 20 weeks, and 44 weeks ]
    Scales to evaluate reward-related eating measured by the Reward-Based Eating Drive Scale (RED-13)



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 65 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  1. All participants will be Veterans between the ages of 18-65 meeting criteria for overweight, with a BMI ≥25.
  2. Participants will meet Diagnostic and Statistical Manual-5 (DSM-5) criteria for BED or subclinical BED
  3. Participants will be willing and able to participate in assessment visits and treatment sessions at University of California, San Diego (UCSD).
  4. Participants will be able to provide data in English through interviews and questionnaires and understand treatment materials in English.
  5. Participants will be willing to maintain contact with the investigators for 11 months.
  6. Participants will be free of serious or unstable medical (current symptoms of angina, stroke, heart disease or other serious medical condition that would make physical activity unsafe or impossible at a moderate level) or psychiatric illness (i.e., active suicidal ideation, history of suicide attempt within 1 year, current unmanaged psychosis, manic episode, anorexia nervosa, bulimia nervosa, or substance abuse within the past year) or psychosocial instability (e.g., homelessness) that could compromise study participation.
  7. Participants will be free from conditions in which exercise or weight loss will be detrimental to the participant's health (e.g., pregnancy); pharmacotherapy for obesity or binge eating disorder (e.g., Orlistat or Meridia) or bariatric surgery within the past 6 months or planning to start such treatments in the next 11 months.
  8. Participants will not be moving out of the San Diego area for the duration of their study enrollment (11 months).
  9. Participants will not be pregnant, planning to get pregnant in the 11-month study period or lactating.
  10. Participants will not be participating in group or individual psychotherapy for binge eating or weight management.
  11. Participants with medical or psychological problems or taking medications that could make adherence with the study protocol difficult or dangerous will not be included.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03678766


Contacts
Layout table for location contacts
Contact: Saori Obayashi, Ph.D 858-246-2879 sobayashi@ucsd.edu
Contact: Kerri Boutelle, Ph.D 858-534-8037 kboutelle@ucsd.edu

Locations
Layout table for location information
United States, California
UCSD Center for Healthy Eating and Activity Research (CHEAR) Recruiting
La Jolla, California, United States, 92093
Contact: Saori Obayashi, PhD    858-246-2879    sobayashi@ucsd.edu   
Contact: Kerri Boutelle, PhD    858-534-8037    kboutelle@ucsd.edu   
Principal Investigator: Kerri Boutelle, PhD         
Sponsors and Collaborators
University of California, San Diego
San Diego Veterans Healthcare System
United States Department of Defense
Investigators
Layout table for investigator information
Principal Investigator: Kerri Boutelle, Ph.D UCSD

Publications:
Layout table for additonal information
Responsible Party: Kerri Boutelle, Professor, University of California, San Diego
ClinicalTrials.gov Identifier: NCT03678766     History of Changes
Other Study ID Numbers: 181015
First Posted: September 20, 2018    Key Record Dates
Last Update Posted: April 16, 2019
Last Verified: April 2019

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Kerri Boutelle, University of California, San Diego:
Overweight
Obesity
Binge Eating
Overeating
Body Mass Index
Weight
Treatment
Intervention
Behavioral Treatment
Additional relevant MeSH terms:
Layout table for MeSH terms
Overweight
Bulimia
Feeding and Eating Disorders
Binge-Eating Disorder
Body Weight
Signs and Symptoms
Mental Disorders
Hyperphagia
Signs and Symptoms, Digestive